Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01727752
Other study ID # NTR1307
Secondary ID
Status Active, not recruiting
Phase N/A
First received November 12, 2012
Last updated October 29, 2014
Start date October 2007
Est. completion date April 2015

Study information

Verified date October 2014
Source Paradigm Spine
Contact n/a
Is FDA regulated No
Health authority Netherlands: Health Counsil of Netherlands
Study type Interventional

Clinical Trial Summary

A Randomized, Blinded Comparison of Surgical Intervention with the Coflex® Interspinous Implant versus Surgical Decompression for Patients with Intermittent Neurogenic Claudication caused by Lumbar Stenosis


Description:

In this investigation, it will be investigated whether the effectiveness of surgical intervention with Coflex® is equivalent to surgical decompression after 12 months in people with intermittent claudication. The main advantage of coflex® might be a faster recovery after surgery, but after long term follow-up it is unknown if this treatment effect remains. Therefore in addition, it will be investigated whether surgical intervention with coflex® is more effective than surgical decompression on short-term follow-up (8 weeks to 6 months) and whether surgical intervention with coflex® is more cost-effective after 12 months than surgical decompression.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 386
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 85 Years
Eligibility Inclusion Criteria:

- signed informed consent

- is 40 to 85 years old at time of surgery

- has INC, as noted by leg/buttock/groin pain with or without back pain. Leg/buttock/groin pain needs to be strongly relieved when flexed such as when sitting in a chair

- has received at least three months of conservative care therapy which may have included, but is not limited to, physical therapy, bracing, systemic and/or injected medications

- has a regular indication for surgical intervention of INC

- has a narrowed lumbar spinal canal, nerve root canal or intervertebral foramen at one or two levels confirmed by MRI

- is physically and mentally willing and able to comply with, or has a caregiver who is willing and able to comply with, the post-operative evaluations.

Exclusion Criteria:

- has cauda equina syndrome defined as neural compression causing neurogenic bowel (rectal incontinence) or bladder dysfunction (bladder retention or incontinence)

- has Paget's disease, severe osteoporosis or metastasis to the vertebrae

- has significant scoliosis (Cobb angle > 25 degrees)

- has a Body Mass Index (BMI) > 40 kg/m2

- has had any surgery of the lumbar spine

- has degenerative spondylolisthesis > grade 1 (on a scale 1 to 4) at the affected level

- has significant instability of the lumbar spine

- has severe comorbid conditions that will increase the risk to the patient or interfere with the evaluability of this study

- has a fused segment at the indicated level.

- has a herniated disk on the level of interest

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Decompression


Locations

Country Name City State
Netherlands Sint Lucas Andreas Ziekenhuis Amsterdam
Netherlands Reinier De Graaf Gasthuis Delft
Netherlands Groene Hart Ziekenhuis Gouda
Netherlands Medical Center Alkmaar Holland
Netherlands Diaconessenhuis Leiden
Netherlands Leiden University Medical Center Leiden
Netherlands Rijnland ziekenhuis, Leiderdorp
Netherlands Canisius-Wilhelmina Ziekenhuis Nijmegen
Netherlands Vlietland Ziekenhuis Schiedam
Netherlands Bronovo Ziekenhuis The Hague
Netherlands HAGA ziekenhuis The Hague
Netherlands Medical Center Haaglanden The Hague/Leidschendam
Netherlands Isala Klinieken Zwolle

Sponsors (1)

Lead Sponsor Collaborator
Paradigm Spine

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Zurich Claudication Questionnaire (ZCQ) ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. 5 years No
Secondary EuroQOL (EQ-5D) The EuroQol (EQ-5D) will be used for the cost utility analysis at the end of the investigation. 5 years No
Secondary MRDQ The 23-points MRDQ is the most widely used patient-assessed measure of health outcome for low back pain. 5 years No
Secondary SF-36 The SF-36 questionnaire relates to the analysis of the general functional status and Quality of Life of patients. 5 years No
Secondary McGill Pain Questionnaire The McGill questionnaire measures the quality aspect of pain, next to the intensity of pain. 5 years No
Secondary VAS Leg Pain Improvement of the Visual Analog Scale (VAS) for leg pain (on the 100 mm scale) compared to control group 5 years No
Secondary Re-operations, revisions, and major complications Assessment of revisions, removals, re-operations, and major device-related complications. 5 years Yes
Secondary Radiographic Assessment Radiographic Assessment of coflex and control group 12 months No